Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 Randomized Clinical Trial
The approval of a new higher dose will provide adult patients with an additional therapeutic option, offering the potential for greater weight loss, the agency stated
Opler explains that men often want to be fit, which means there could be consumer interest in muscle building drugs
According to data from the Centers for Disease Control (CDC), approximately 1 in 31 children 8 years of age (3.2%) were identified as having Autism Spectrum Disorder (ASD)
Although patients may regain nearly two-thirds of their lost weight on GLP-1 RAs after cessation of the drug 16 , this early positive reinforcement may serve as an incentive to pursue a long-term, multipronged approach to combat obesity
Every person is different, but the most effective GLP-1 medications can lower the A1c by 12%